Patents by Inventor Carl-Henrik Heldin

Carl-Henrik Heldin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5219759
    Abstract: DNA encoding two forms of PDGF A-chain polypeptide, the construction of expression vectors for expressing such DNA in yeast and mammalian cells, and the expression of such DNA in yeast and mammalian cells to produce active PDGF A-chain homodimer and active PDGF A-chain/B-chain heterodimer are disclosed.
    Type: Grant
    Filed: August 27, 1990
    Date of Patent: June 15, 1993
    Assignee: Chiron Corporation
    Inventors: Carl-Henrik Heldin, Christer Betsholtz, Bengt Westermark, Timothy J. Knott, James Scott, Graeme I. Bell
  • Patent number: 5177197
    Abstract: Purified protein known as platelet TGF-.beta.1-BP (transforming growth factor-.beta.1-binding protein) is described. The protein is useful for purposes such as the production of antisera which are useful in identifying complexes containing the binding protein, as well as in formation of labeled probes. Also described are purified DNA which expresses the protein, as well as messenger RNA translated into the protein. The protein contains 16 epidermal growth factors (EGF) like repeats, and 3 repeats not found in other proteins. The DNA for the protein is found to contain consensus sequences for hydroxylation of asparagine/aspartic acid residues, and, in the purified protein beta hydroxylated asparagine residues were found.
    Type: Grant
    Filed: February 27, 1990
    Date of Patent: January 5, 1993
    Assignee: Ludwig Institute for Cancer Research
    Inventors: Tetsuto Kanzaki, Anders Olofsson, Anita Moren, Christer Wernstedt, Ulf Hellman, Kohei Miyazono, Lena Claesson-Welsh, Carl-Henrik Heldin